Classification of Recombinant Biologics in the EU: Divergence Between National Pharmacovigilance Centers
Crossref DOI link: https://doi.org/10.1007/s40259-015-0149-y
Published Online: 2015-11-30
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Klein, Kevin
De Bruin, Marie L.
Broekmans, Andre W.
Stolk, Pieter
Funding for this research was provided by:
Top Institute Pharma (NL)
License valid from 2015-11-30